Bio Simulation market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023


Select Your License Type


samplerequest
makeanenquiry
download
Discount


The report on Global Bio Simulation market provides qualitative and quantitative analysis for the period of 2015 to 2023.  According to report the Global Bio Simulation market is expected to grow at a CAGR between 16.2% to 16.7% over the forecast period of 2017 – 2023.The global Bio Simulation market was worth USD 1.05 billion in 2015 and expected to reach USD XX billion by 2023.


                                Figure 1: Global Bio Simulation by value 2017 – 2023



Market Insights:

The report identified that Global Bio Simulation is driven by factors such as Growth in the Biologics and Biosimilars Market and Increased Use of Personalized Medicines, Increase in R&D Investments in the Pharmaceutical and Biotechnology Industries, and, Growth in the Pharmaceutical and Biotechnology Industries. While the restraining factors include Lack of Trained Professionals, and Lack of Standardization. Further, the report identifies the opportunities in the world market as Emerging Applications.
Biosimulation provides a systematic approach for integrating the clinical and biological data into functional metabolic pathways. The applications of biosimulation include obtaining a quantitative understanding of regulation of blood levels and glucose simulated insulin secretion in order to investigate the role the various physiological processes play in diabetes and others. Biosimulation is used for target identification & validation, lead discovery & optimization, preclinical testing and clinical trials.  The areas of future research in biosimulation include obtaining a better understanding of disease heterogeneity and the biological changes that occur during disease progression to predict the effects of various therapeutic approaches on different categories of people.
 
Segments Covered:
The report on Global Bio Simulation market covers Segments such as Product, Application, End User and region. The products include drug discovery, drug development, and others (defense, industrial bioprocessing, nutraceuticals, and agri-food production). The drug development application segment is further classified into preclinical testing and clinical trials. The drug discovery segment is divided into target identification & validation and lead identification & optimization. The end users for this market are academic and government research institutes, pharmaceutical and biotechnology companies, contract research organizations (CROs), regulatory authorities, and other end users (defense, nutraceuticals companies, and food and agricultural companies).
 
Geographic Coverage and Analysis:
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015 – 2023.


                                     Figure 2: Global Bio Simulation market by region




The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. North America dominated the global bio simulation market and holds more than half of the share value as compared to total global sale. This growth in North America is significantly driven by off patenting of many drugs and search for new drug moiety. Europe stands next to North America for global bio simulation market where growth is majorly driven by government initiatives. Asia-pacific is emerging market where the growth is driven by increase in number of CRO’s.

Companies Profiled:
The report provides profiles of the companies in the Global Bio Simulation market such as,Certara USA, Inc., Simulation Plus Inc., Dassault Systèmes SA, Medtronic, Advanced Chemistry Development, Inc., Advanced Chemistry Development, Inc., Chemical Computing Group, Inc., Entelos Holding Corporation, Genedata Ag, Physiomics PLC, and Rhenovia Pharma Ltd..
 
Report Highlights:
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the Global Bio Simulation market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider.
The report provides insights into the market using analytical tools such as Porter’s five forces analysis and DRO analysis of Bio Simulation market. Moreover, the study highlights current market trends and provides forecast from 2016 to 2023. We also have highlighted future trends in the Bio Simulation market that will impact the demand during the forecast period.
Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market.
This report will help manufacturers, suppliers and distributors of the Bio Simulation market to understand the present and future trends in this market and formulate their strategies accordingly.

1. Preface

1.1. Report description
1.2. Research methods
1.3. Research approaches

2. Executive summary
3. Global Bio Simulation market Overview

3.1. Introduction
3.2. Market dynamics

3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities

3.3. Porter’s five forces analysis
3.4. Macro indicator and factor analysis
3.5. Demographic Factor Analysis by Regions

3.5.1. North America (NAFTA)
3.5.2. Europe
3.5.3. Asia-Pacific
3.5.4. South America

3.6. Competitive landscape in the Bio Simulation market

4. Global Bio Simulation market Analysis by Product 2017 – 2023 

 
4.1. Software

4.1.1 PK/PD Modeling and Simulation Software
4.1.2 Molecular Modeling and Simulation Software
4.1.3 Pbpk Modeling and Simulation Software
4.1.4 Toxicity Prediction Softwar
4.1.5 Trial Design Software
4.1.6 Other Software

4.2. Services

4.2.1 In-House Services
4.2.2 External/Contract Services

5. Global Bio Simulation market Analysis, by Application 2017 – 2023  

 
5.1. Drug Development

5.1.1 Preclinical Testing
5.1.1.1 PK/PD
5.1.1.2 ADME/TOX
5.1.2 Clinical Trials

5.2. Drug Discovery

5.2.1 Target Identification and Validation
5.2.2 Lead Identification and Optimization

5.3. Other Applications

6. Global Bio Simulation market Analysis, by End User 2017 – 2023 

 
6.1. Pharmaceutical and Biotechnology Companies
6.2. Academic and Government Research Institutes
6.3. Contract Research Organizations
6.4. Regulatory Authorities
6.5. Other End Users

7. Global Bio Simulation market Analysis, by Region 2017 – 2023

        
7.1. North America

7.1.1. North America Bio Simulation market by Product
7.1.2. North America Bio Simulation market by Application
7.1.3. North America Bio Simulation market by End User

7.2. Europe

7.2.1. Europe Bio Simulation market by Product
7.2.2. Europe Bio Simulation market by Application
7.2.3. Europe Bio Simulation market by End User

7.3. Asia-Pacific

7.3.1. Asia-Pacific Bio Simulation market by Product
7.3.2. Asia-Pacific Bio Simulation market by Application
7.3.3. Asia-Pacific Bio Simulation market by End User

7.4. Rest of the World (RoW)

7.4.1. Rest of the World (RoW) Bio Simulation market by Product
7.4.2. Rest of the World (RoW) Bio Simulation market by Application
7.4.3. Rest of the World (RoW) Bio Simulation market by End User

8. Companies Covered  

8.1. Certara USA, Inc.
8.2. Simulation Plus Inc.
8.3. Dassault Systèmes SA
8.4. Medtronic
8.5. Advanced Chemistry Development, Inc.
8.6. Chemical Computing Group, Inc.
8.7. Entelos Holding Corporation
8.8. Genedata Ag
8.9. Physiomics PLC
8.10. Rhenovia Pharma Ltd.


Got a Question?

If you have a question to ask our analyst, just fill this form and send it across, our representative will get in touch with you shortly.